Loading clinical trials...
Loading clinical trials...
A Phase 3B, Multicenter, Assessor-Blinded Study of the Tolerability of Clindamycin 1%-Tretinoin 0.025% Gel Used in Conjunction With Benzoyl Peroxide 4% Wash in Subjects With Mild to Moderate Facial Acne Vulgaris
Conditions
Interventions
CTGel/ BPO Wash
Soap Free Cleanser and CTGel
Locations
5
United States
Dermatology Associates Research
Coral Gables, Florida, United States
Grekin Skin Institute
Warren, Michigan, United States
Dermatology Consulting Services
High Point, North Carolina, United States
The Skin Wellness Center, PC
Knoxville, Tennessee, United States
Premier Clinical Research
Spokane, Washington, United States
Start Date
April 1, 2009
Primary Completion Date
June 1, 2009
Completion Date
June 5, 2009
Last Updated
May 24, 2017
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT07348978
Lead Sponsor
Stiefel, a GSK Company
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions